NCT06541639
- Conditions
- Advanced or Recurrent Solid Tumors
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Clinical trial condition
Advanced or Recurrent Solid Tumors
Explore clinical trials studying Advanced or Recurrent Solid Tumors. Study availability and eligibility vary by location and protocol.
4 public trials
2 recruiting studies
Advanced or Recurrent Solid Tumors trial results
Recruiting
NCCH2006/MK010 Trial (FORTUNE Trial)
NCT04962867
- Conditions
- Acrocephalosyndactylia, Advanced or Recurrent Solid Tumors, Bone Diseases, +12 more
- Locations
-
- National Cancer Center Hospital Chuo-ku, Tokyo, Japan
- Kanagawa Cancer Center Yokohama, Kanagawa, Japan
- Tohoku University Hospital Aoba-ku, Sendai, Miyagi, Japan
- Kyushu University Hospital Higashi-Ku, Fukuoka, Japan
NCT01285453
- Conditions
- Advanced or Recurrent Solid Tumors
- Locations
-
- Novartis Investigative Site Aichi, Japan
- Novartis Investigative Site Osaka, Japan
Completed
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
NCT01286987
- Conditions
- Adnexal Diseases, Advanced or Recurrent Solid Tumors, Breast Diseases, +49 more
- Locations
-
- Scottsdale Healthcare Scottsdale, Arizona, United States
- Virginia G. Piper Cancer Center Research Pharmacy Scottsdale, Arizona, United States
- (IRB# 12-000131) Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States
- Ronald Reagan UCLA Medical Center Los Angeles, California, United States